Manuel Pedregal

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

HER2-directed TAC T cells in solid tumors: a step forward, but not yet a therapeutic leap.

HER2-directed TAC T cells in solid tumors: a step forward, but not yet a therapeutic leap.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: June 18, 2026

Tumor-type specific methylation patterns of MTAP in human samples and cell lines.

Tumor-type specific methylation patterns of MTAP in human samples and cell lines.

Journal: Clinical epigenetics

Published: January 17, 2026

Landscape of T-cell engagers in solid tumors.

Landscape of T-cell engagers in solid tumors.

Journal: The oncologist

Published: October 01, 2025

In silico evaluation of the immunogenic profile of lung cancers with SMARCA4 genetic alterations.

In silico evaluation of the immunogenic profile of lung cancers with SMARCA4 genetic alterations.

Journal: Scientific reports

Published: April 24, 2024

Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D.

Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D.

Journal: International journal of molecular sciences

Published: April 09, 2024

Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.

Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.

Journal: Cancer immunology, immunotherapy : CII

Published: March 22, 2024

Prolonged survival in a patient with pbrm1 mutated metastatic cholangiocarcinoma receiving tazemetostat.

Prolonged survival in a patient with pbrm1 mutated metastatic cholangiocarcinoma receiving tazemetostat.

Journal: NPJ precision oncology

Published: March 12, 2024

Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives.

Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 29, 2023

Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2.

Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2.

Journal: International journal of molecular sciences

Published: November 29, 2023

Immunotherapy for Peritoneal Metastases from Gastric Cancer: Rationale, Current Practice and Ongoing Trials.

Immunotherapy for Peritoneal Metastases from Gastric Cancer: Rationale, Current Practice and Ongoing Trials.

Journal: Journal of clinical medicine

Published: August 31, 2021

A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy.

A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy.

Journal: European urology focus

Published: August 21, 2020

A Call for Standardized Reporting of Adverse Events.

A Call for Standardized Reporting of Adverse Events.

Journal: European urology

Published: June 10, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026